<DOC>
	<DOCNO>NCT00481299</DOCNO>
	<brief_summary>Prolactin suggest influence insulin resistance , scarce data available metabolic profile patient prolactinoma . The purpose protocol evaluate cardiovascular disease risk factor woman prolactinoma treat dopamine agonist study influence disease control anthropometry metabolic profile .</brief_summary>
	<brief_title>Insulin Resistance Women With Prolactinoma</brief_title>
	<detailed_description>A cross-sectional study perform non-obese premenopausal woman prolactinoma treat dopamine agonist evaluate regard glucose , insulin , Homeostasis Model Assessment ( HOMA ) , lipid profile , C reactive protein ( CRP ) , body mass index ( BMI ) , waist circumference , prolactin , estradiol , testosterone , sex hormone bind globulin ( SHBG ) . They compare control woman similar age BMI distribution .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Prolactinoma</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Prolactinoma Female gender Premenopausal Obesity ( BMI ≥ 30 kg/m² ) Diabetes mellitus Hypertension GH deficiency Hypothyroidism Primary hypogonadism Adrenal insufficiency Pituitary surgery</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>48 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Insulin</keyword>
	<keyword>glucose</keyword>
	<keyword>lipid</keyword>
	<keyword>prolactinoma</keyword>
	<keyword>hyperprolactinemia</keyword>
</DOC>